Literature DB >> 16612291

Timing of pulmonary emboli after trauma: implications for retrievable vena cava filters.

Ronald F Sing1, Steven M Camp, B Todd Heniford, Edmund J Rutherford, Stephanie Dix, Patrick M Reilly, James H Holmes, Elliott Haut, Awori Hayanga.   

Abstract

BACKGROUND: Four recent reports of the retrieval of optional vena cava filters (VCF) in trauma patients had average implant durations of 10, 19, and 19 days (one not specified). Two patients in these studies had pulmonary emboli after VCF removal. No evidence-based guidelines exist on the appropriate time to remove optional VCF. The purpose of this study was to examine the timing of pulmonary emboli (PE) and determine the optimal time to remove optional VCFs.
METHODS: A multicenter retrospective chart review of trauma patients who had a postinjury PE between January 2001 and December 2004 was performed. We examined the demographics, prophylaxis at the time of PE (pharmacologic [unfractionated or low molecular weight heparin] or sequential compression devices [SCD]), diagnostic test used, timing of PE from the date of injury, and survival outcome.
RESULTS: In all, 146 patients were identified, mean age 45.1 (+/- 21.1 SD); Injury Severity Score 18.0 (+/- 12.1 SD). Diagnosis was obtained by spiral computed tomography (N = 93), pulmonary arteriogram (N = 18), V/Q (N = 26), autopsy (N = 6), clinical (N = 6), and unknown (N = 3). Overall mortality was 17.8% (N = 26). Pulmonary embolism was felt to contribute to or was the cause of death in 85% (N = 22) of these patients. Two late PE deaths occurred (days 21 and 43). Sixty (37%) patients had pharmacologic prophylaxis at the time of PE and 83 (50.9%) had SCDs. Average time from injury to PE was 7.9 days (+/- 8.1 SD), the longest being 43 days postinjury. Eleven percent of PE occurred after 21 days, including fatal PE.
CONCLUSIONS: Clinical criteria defining the time to remove optional VCFs without exposing patients to the risk of PE by removing a filter too soon should be determined.

Entities:  

Mesh:

Year:  2006        PMID: 16612291     DOI: 10.1097/01.ta.0000210285.22571.66

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  9 in total

1.  Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study.

Authors:  K M Ho; M Burrell; S Rao; R Baker
Journal:  Br J Anaesth       Date:  2010-09-22       Impact factor: 9.166

2.  Predictors of early versus late timing of pulmonary embolus after traumatic injury.

Authors:  Scott C Brakenridge; Seth M Toomay; Jean L Sheng; Larry M Gentilello; Shahid Shafi
Journal:  Am J Surg       Date:  2010-04-10       Impact factor: 2.565

3.  Optional inferior vena cava filters in the trauma patient.

Authors:  Hamed Aryafar; Thomas B Kinney
Journal:  Semin Intervent Radiol       Date:  2010-03       Impact factor: 1.513

4.  Prevalence and main determinants of early post-traumatic thromboembolism in patients requiring ICU admission.

Authors:  F Kazemi Darabadi; M A Jafari Zare; Z Torabi Goodarzi; P Namdar
Journal:  Eur J Trauma Emerg Surg       Date:  2017-08-08       Impact factor: 3.693

5.  Retrievable inferior vena cava filters in high-risk trauma and surgical patients: factors influencing successful removal.

Authors:  Joshua L Hermsen; Anna R Ibele; Lee D Faucher; Jennifer K Nale; Michael J Schurr; Kenneth A Kudsk
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

6.  Post-traumatic pulmonary embolism in the intensive care unit.

Authors:  Mabrouk Bahloul; Anis Chaari; Hassen Dammak; Fatma Medhioub; Leila Abid; Hichem Ksibi; Sondes Haddar; Hatem Kallel; Hedi Chelly; Chokri Ben Hamida; Mounir Bouaziz
Journal:  Ann Thorac Med       Date:  2011-10       Impact factor: 2.219

7.  Utilization of alteplase in trauma victim with an open abdomen.

Authors:  Sharolyn L Martin; M Geno Tellez
Journal:  J Emerg Trauma Shock       Date:  2011-07

8.  Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol.

Authors:  Kwok M Ho; Sudhakar Rao; Stephen Honeybul; Rene Zellweger; Bradley Wibrow; Jeffrey Lipman; Anthony Holley; Alan Kop; Elizabeth Geelhoed; Tomas Corcoran
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

9.  Sentry Bioconvertible Inferior Vena Cava Filter: Study of Stages of Incorporation in an Experimental Ovine Model.

Authors:  Peter A Gaines; Frank D Kolodgie; Gordon Crowley; Steven Horan; Megan MacDonagh; Emily McLucas; David Rosenthal; Ashley Strong; Michael Sweet; Deepal K Panchal
Journal:  Int J Vasc Med       Date:  2018-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.